ArticleCureus2025

Sustained Efficacy and Safety of Tildrakizumab in Psoriasis Vulgaris Despite Multiple Prolonged Treatment Interruptions: A Case Report.

Kazuki Yatsuzuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.